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Bone morphogenetic protein-1 (BMP-1)/tolloid proteinases are fundamental to regulating dorsal
ventral patterning and extracellular matrix deposition. In mammals there are four proteinases,
the splice variants BMP-1 and mammalian tolloid (mTLD), and tolloid like-1 and -2 (TLL-1/2).
BMP-1 has the highest catalytic activity and lacks three non-catalytic domains. We demonstrate that
TLL-1, which has intermediate activity, forms a calcium-ion dependent dimer with monomers
stacked side-by-side. In contrast, truncated TLL-1 molecules having the same shorter structure as
BMP-1 are monomers and have improved activity towards their substrate chordin. The increased
activity exceeds not only that of full-length TLL-1 but also BMP-1.
Structured summary:
MINT-7386098: BMP-1 (uniprotkb:P13497) cleaves (MI:0194) Chordin (uniprotkb:Q9H2X0) by protease
assay (MI:0435)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under the Elsevier OA license. 1. Introduction
Bone morphogenetic protein-1 (BMP-1)/tolloid (TLD) family
proteinases serve two main purposes; ﬁrstly the processing of
extracellular matrix (ECM) precursors which range from structural
components such as ﬁbrillar collagens [1], enzymes [2], cellular
anchoring proteins [3,4] and small leucine-rich proteoglycans
[5,6]. Secondly, the release of transforming growth factor (TGF)-b
superfamily members, including BMP-2 and -4, growth and differ-
entiation factors (GDF) 8/11 and TGF-b1 from their latent com-
plexes. Through these actions, BMP-1/TLD proteinases affect
processes ranging from dorsal ventral patterning, growth of skele-
tal muscle, neurogenesis, to cellular behaviour [7–10].
BMP-1/TLD proteinases have an N-terminal protease domain
related to the digestive enzyme astacin [11] followed by non-cata-
lytic CUB (Complement/Uegf/BMP-1) and epidermal growth factor-
like (EGF) domains and a short C-terminal sequence (Fig. 1A).
mTLD, TLL-1 and TLL-2 have 5 CUB and 2 EGF-like domains
whereas BMP-1 lacks two CUB and one EGF C-terminal domains.
There is evidence that the non-catalytic domains have a negative
regulatory role [12,13] and we recently provided an explanation
as to why mTLD is a poor proteinase relative to BMP-1 [14]. Our
ﬁndings illustrated that BMP-1 is a monomer whereas mTLD formsal Societies. Published by Elsevier
. Baldock).a dimer in the presence of calcium-ions, which restricts its chor-
dinase activity by a substrate exclusion mechanism. It is unknown
whether this mechanism extends to other BMP-1/TLD family mem-
bers, and in particular TLL-1 which is a more efﬁcient proteinase
than mTLD.
In the present report, we provide evidence that TLL-1 forms a
dimer and show that truncated forms of TLL-1 having the same do-
main structure as BMP-1 are monomers, irrespective of the pres-
ence/absence of the unique C-terminal sequence. Surprisingly,
the truncated TLL-1 molecules have higher chordinase activity
not only than full-length TLL-1, but also BMP-1. Together these
data provide evidence that the protease activity of TLL-1 is re-
stricted by substrate exclusion.
2. Materials and methods
2.1. Expression and puriﬁcation of recombinant proteins
TLL-1 was generated from an IMAGE clone comprising the ﬁrst
1870 base pairs and the remaining 1169 base pairs synthesized by
Genescript with a 30 V5-His(6) tag and ligated into the pCEP4 vector
(Invitrogen) using Kpn1 and XhoI. TLL-1 molecules terminating
after CUB3 with (TLL1TC3-T) and without (TLL1TC3) the C-terminal
sequence, were ampliﬁed by PCR using TLL-1 and ligated into the
pCEP-Pu vector using Not1 and Xho1. 293-EBNA cells were cul-
tured and transfected as described in [14]. TLL-1 and variants wereB.V. Open access under the Elsevier OA license. 
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Fig. 1. (A) Domain structures are displayed schematically. MP, metalloproteinase domain; C, CUB domain; E, EGF-like domain; T, C-terminal sequence. Protein derived from
the Bmpl gene is shown in white and from the Tll1 gene in grey. (B) Reducing SDS–PAGE of TLL-1, molecular weight markers in kDa are indicated. (C) MALLS analysis of TLL-1,
in the presence of 1 mM CaCl2 the molecular mass was 219500 Da (i) but in 2 mM EDTA it was 105600 Da (ii). The theoretical molecular mass of TLL-1 (including puriﬁcation
tag) is 100465 Da.
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chromatography as were BMP-1, mTLD and chordin as described
in [14]. Enzyme and chordin concentrations were quantiﬁed based
on comparison to known amounts of bovine serum albumin (BSA)
using SDS–PAGE and GeneTools software (SynGene). A range of de-
ﬁned BSA quantities are visualised and a calibration curve plotted.
The amount of enzyme in a known volume can then be
determined.
2.2. Multi-angle laser light scattering (MALLS)
Samples (0.5 ml) were separated in 10 mM Tris–HCl (pH 7.4)
containing 0.5 M NaCl in the presence of either 1 mM CaCl2 (Super-
dex-200 10/300 GL column) or 2 mM EDTA (Superdex-75 10/300
GL column) at 0.71 ml/min and passed through aWyatt EOS 18-an-
gle laser photometer with the 13th detector replaced with a Wyatt
QELS detector. This was coupled to a Wyatt Optilab rEX refractive
index detector and the hydrodynamic radius, molecular weight
moments and concentration of peaks analysed using Astra5.3.2.
2.3. Analytical ultracentrifugation (AUC)
AUC experiments were performed using an XL-A ultracentrifuge
as described in [14]. Equilibrium sedimentation was performed at
4 C, using rotor speeds of 7, 12 and 19000 rpm (35670, 10483 and
26280 g) with scanning at 230 and 280 nm after equilibrium was
reached (14 h). Association kinetics was performed using concen-
trations between 0.5 and 1.4 lM and data analysed using Sedphat
[15]. Velocity sedimentation was performed at 40000 rpm
(116480 g) at 20 C (TLL-1) or 45000 rpm (147420 g) at 10 C
(TLL1TC3 variants) with the sedimenting boundary monitored
every 90 seconds (TLL-1) or 3 min (TLL1TC3 variants) for 200 scans.
Protein concentrations were 174 lg/ml (TLL-1), 59 lg/ml
(TLL1TC3), 47 lg/ml (TLL1TC3-T in Ca2+) and 196 lg/ml
(TLL1TC3-T in EDTA). Data was interpreted using Sedﬁt [16]. Bead
models were generated using the atomic coordinates of homolo-
gous domains in the modeling software SOMO [17].2.4. TEM
TLL-1 (10 lg/ml) in the presence of 1 mM CaCl2 was absorbed
onto EM grids and stained with 4% (w/v) uranyl acetate and ob-
served in an FEI Tecnai12 TEM at 120 keV. Images were recorded
on a CCD camera at 69000 magniﬁcation between 0.5 and
1.5 lm defocus and processed using Imagic5 software [18]. Four
hundred and eighty-ﬁve particles were band-pass ﬁltered with
high and low frequency cut-offs of 20 Å and 180 Å.
2.5. Activity assays
Puriﬁed chordin (2 lg) was incubated in the presence or ab-
sence of 30 ng enzyme in 50 mM Tris–HCl (pH 7.4) containing
150 mM NaCl and 5 mM CaCl2 at 37 C for 4 h [19]. Reactions were
stopped by adding LDS sample buffer (Invitrogen) and heating to
95 C for 5 min. Reaction products were separated by SDS–PAGE
and visualised by silver staining. Chordinase assay products were
quantiﬁed by densiometry using SynGene software.3. Results
Puriﬁed TLL-1 (Fig. 1B) eluted from SEC-MALLS in buffer con-
taining calcium as a single peak with a mass of 219500 Da
(Fig. 1C(i)) suggesting TLL-1 is a dimer in solution. To determine
whether the TLL-1 dimer requires the presence of calcium, we ana-
lysed samples in the presence of EDTA (Fig. 1C(ii)). Under these
conditions, the mass was reduced to 105600 Da, in good agree-
ment with a monomer (Table 1). The strength of TLL-1 self-associ-
ation was assessed using sedimentation equilibrium AUC (data not
shown). TLL-1 was predominantly dimeric with very strong self-
association (Kd = 2 nM at 0.5 mM [CaCl2]).
To investigate the dimeric arrangement of TLL-1, we used sedi-
mentation velocity AUC. In the presence of 1 mM calcium-ions, the
predominant species has an S20,W of 8.88 (Fig. 2A). This species has
a mass estimate of 196000 Da, similar to that expected for a dimer.
Table 1
Data was collected by (a) MALLS, (b) AUC: molecular weight (MW) in Daltons;
hydrodynamic radius (Rh) in nm; sedimentation coefﬁcient (S20,w) and frictional
coefﬁcient (f/f0). Theoretical MWs (including puriﬁcation tag) are 100465 Da (TLL-1),
68341 Da (TLL1TC3-T) and 67113 Da (TLL1TC3). ND = not determined.
MWa MWb Rh,b S20,W f/fo
TLL-1 Ca2+ 219500 ± 659 196000 5.52 8.88 ± 0.15 1.44
73900 5.33 4.59 ± 0.21 1.75
TLL-1 EDTA 105600 ± 12672 ND ND ND ND
TLL1TC3 Ca2+ ND 67100 3.36 4.91 ± 0.33 1.26
TLL1TC3-T Ca2+ ND 65990 3.55 4.73 ± 0.38 1.32
TLL1TC3-T EDTA ND 67200 3.67 4.59 ± 0.32 1.36
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ated bead models and a horseshoe-like conformation (Fig. 2B) gave
the best ﬁt to the experimentally-derived hydrodynamic radius
(Rh) of 5.33 nm (Table 1). We used single particle TEM to investi-
gate the arrangement of the dimer, following classiﬁcation it was
evident that TLL-1 particles were present in a single orientation
showing side-by-side stacking of monomers (Fig. 2C).
To investigate if TLL-1 is restricted by a substrate exclusion
mechanism we made a TLL-1 variant with the same domain struc-
ture as BMP-1 (TLL1TC3-T with unique C-terminal sequence). Due
to aggregation we were unable to obtain a mass for TLL1TC3-T
using MALLS, therefore we analysed protein samples by sedimen-
tation velocity AUC. In the presence of EDTA or calcium, the c(s)
proﬁle are the same with a predominant species at 3.5 Sapp
(Fig. 3A) suggesting almost all protein is monomeric (Table 1).
Since there are no species at higher (>4) Sapp in samples containing
calcium, we conclude that TLL1TC3-T does not form calcium-ion
dependent dimers.
In a previous report, a construct analogous to TLL1TC3-T lacking
the C-terminal sequence formed oligomeric aggregates observed
on non-reducing SDS–PAGE thought to be due to misfolding [12].
To test this possibility, we generated TLL1TC3 which lacks the C-2 4 6 8 10 12 14
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Fig. 2. (A) Sedimentation velocity AUC of TLL-1 in the presence of 1 mM CaCl2. The major
1 monomer. A horseshoe-like conformation gives the closest ﬁt to experimental Rh of 5
representative classes are shown; the number of particles in each class is indicated (boxterminal sequence. Neither variant (with or without the C-terminal
sequence) showed evidence of aggregation (Fig. 3B). To conﬁrm the
oligomeric status of TLL1TC3 we used sedimentation velocity AUC.
In the presence of calcium-ions the c(s) proﬁle is almost identical
to that of TLL1TC3-T (Fig. 3C), suggesting that TLL1TC3 is also
monomeric.
To determine the proteolytic activity of the TLL-1 variants, we
compared their chordinase activity to that of mTLD, BMP-1 and
TLL-1 (Fig. 3D and E). Chordinase activity was detected for mTLD
but this was considerably lower than that of BMP-1 and TLL-1,
which appear to have similar levels of chordinase activity. How-
ever, the truncated forms of TLL-1 are approximately twice as efﬁ-
cient as TLL-1 at processing chordin.
4. Discussion
In this study we ﬁnd that TLL-1 forms a calcium-dependent di-
mer via a side-by-side stacking of monomers and that the dimer
has a much tighter association than mTLD. We also show that
the region responsible for self-association resides in the C-terminal
three domains. These ﬁndings suggest dimerisation is most likely a
feature of all mammalian BMP-1/TLD family members that have
EGF2, CUB4 and CUB5. Based on these data, we believe that the
proteolytic activity of the TLL-1 dimer is restricted by a substrate
exclusion mechanism that requires the presence of the C-terminal
domains. This conclusion is based on the observations that mono-
meric forms of TLL-1 lacking the C-terminal domains are more efﬁ-
cient chordinases than the full-length molecule and these ‘‘BMP-1
forms” of TLL-1 are also more efﬁcient chordinases than BMP-1.
This latter observation suggests that differences in activity be-
tween TLL-1 and mTLD are due to variations in amino acid residues
rather than gross mechanistic differences.
This is further supported by an independent study in which the
proteinase activity of a construct analogous to TLL1TC3-T was
investigated [12]. This molecule was described as being more efﬁ-
cient than full-length TLL-1 at cleaving procollagen I and probigly-Rh 5.67 nm         Rh 5.17 nm           Rh 4.8 nm
ity of protein is present as a dimer at 8.3 Sapp. (B) Bead models generated for the TLL-
.33 nm. (C) The TLL-1 dimer was investigated using single particle TEM. (i) Three
size = 21.6 nm). Potential dimer packing models are shown in more detail in [14].
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Fig. 3. (A) Sedimentation velocity AUC of TLL1TC3-T in the presence of 1 mM CaCl2 (solid line) and 2 mM EDTA (dotted line). The peak at 3.5 Sapp corresponds to the
monomer. (B) Non-reducing SDS–PAGE of truncated TLL-1 variants. Molecular weight markers in kDa are indicated. (C) TLL1TC3 appears almost identical to TLL1TC3-T when
analysed by sedimentation velocity AUC. (D) Silver stained SDS–PAGE of chordin following incubation with enzymes, the chordin domain structure is shown (CR, cysteine-
rich repeat; myc, c-myc epitope; (H)6, poly-histidine tag; arrows indicate cleavage sites). (E) Densitometric analysis of chordin cleavage is shown for each enzyme represented
as the amount of product (intermediate fragment) relative to substrate (full-length chordin). Data are the mean of three independent experiments ± S.E. (F) Table showing the
values from the densitometric analysis used to plot (E).
660 R. Berry et al. / FEBS Letters 584 (2010) 657–661can. However, what was also apparent in their results, is that this
molecule was also more efﬁcient than BMP-1. These data support
our ﬁndings and suggest the substrate exclusion mechanism that
restricts the activity of TLL-1 extends to other substrates.
We also ﬁnd that the presence or absence of the C-terminal se-
quence has little effect on the chordinase activity of truncated TLL-
1 molecules. In a previous report, it was observed that a molecule
analogous to TLL1TC3 was a poor C-proteinase whereas with the C-
terminal sequence it was highly efﬁcient [12]. Since the form lack-
ing the C-terminal sequence was observed to form aggregates,
these differences were thought to be due to misfolding, and it
was hypothesised that the C-terminal sequence was required for
correct folding. In contrast, our studies reveal the presence or ab-
sence of the C-terminal sequence has no effect on the oligomericstatus or chordinase activity of these molecules. These discrepan-
cies can be explained by small differences in the CUB3 domain.
In the previous report, the molecule terminated after K724. Our do-
main boundary was determined by analysis of the intron-exon
boundary and contained an additional six amino acids (up to
D730). Presumably these aided in the correct folding of our
molecules.
The difference in activity between mTLD and TLL-1 could be due
to subtle differences in the intrinsic afﬁnity of the BMP-1/mTLD
and TLL-1 protease domains for substrates. In support of this, chor-
din cleavage by the isolated protease domains from BMP-1/mTLD
and TLL-1 showed that the TLL-1 domain is signiﬁcantly more efﬁ-
cient [12]. Alternatively, differences in the afﬁnity of the non-cat-
alytic domains for chordin may provide an explanation. Despite
R. Berry et al. / FEBS Letters 584 (2010) 657–661 661the similarities in overall architecture, the strength of TLL-1 self-
association is greater than mTLD. It is conceivable that this may re-
sult in different patterns of activity in vivo. The expression of Bmpl
and Tll1 overlap in a number of tissues [20], differences in self-
association could favour the effect of one proteinase depending
on the calcium and/or protein concentrations present. Our ﬁndings
also raise the possibility of mTLD/TLL-1 heterodimers, which could
add another layer of complexity.
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